Drug
Xenetix
Xenetix: highest development phase Post-Market, developed by Guerbet. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Guerbet
Trials
| Drug | Phase | Indication |
|---|---|---|
| Xenetix NCT00347022 | Post-Market | Diagnostic Imaging |
Latest
No recent events.
Follow Xenetix on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.